SERF1A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-57943
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: SSGGQKSESKMSAGPHLPLKAPRENPCFPLPAAGGSR
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SERF1A Antibody
Immunocytochemistry/ Immunofluorescence: SERF1A Antibody [NBP2-57943]
Immunocytochemistry/Immunofluorescence: SERF1A Antibody [NBP2-57943] - Staining of human cell line HEK 293 shows localization to nuclear bodies.Applications for SERF1A Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF, Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SERF1A
Alternate Names
FAM2B, h4F5, H4F5small EDRK-rich factor 1,4F5, Protein 4F5, SERF1, SMA modifier 1, small EDRK-rich factor 1A (telomeric), SMAM1FAM2ASERF1B, spinal muscular atrophy-related gene H4F5
Gene Symbol
SERF1A
Additional SERF1A Products
Product Documents for SERF1A Antibody
Product Specific Notices for SERF1A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...